GL1X · GenesisL1 explorer

MolNFT v1 · #109560 · protein

Crystal structure of OP0595 complexed with ctx-M-44

4X69 · Beta-lactamase toho-1: “Crystal structure of OP0595 complexed with ctx-M-44”. X-ray diffraction, 1 ligand (OP0), 3 pockets (best druggability 0.66). MolNFT v1 #109560 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4X69
Type
protein
Length
522 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase toho-1
EC
3.5.2.6
UniProt
Q47066
Ligands
OP0
Pockets
3 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BBeta-lactamase toho-1 (EC 3.5.2.6)protein26143% helix, 20% strandQ47066

Ligands and binding sites

  • OP0 · (2S,5R)-N-(2-aminoethoxy)-1-formyl-5-[(sulfooxy) amino]piperidine-2-carboxamide · ligand · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17210.660.7573OP0
2930.380.7620OP0
3520.350.7918EDO

Interfaces

1 interface between chains.

  • A–B · 293 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 4X69 · Crystal structure of OP0595 complexed with CTX-M-44 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q47066 · AlphaFold monomer V2.0 prediction for beta-lactamase toho-1 (Q47066) · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.